• 1
    Mygind N. Glueocorticosteroids and rhinitis. Allergy 1993;48:47690.
  • 2
    Pipkorn U, Proud D, Lichtenstein LM, Kagey-Sobotka A, Norman PS, Naclerio RM. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med 1987;316:150510.
  • 3
    Naclerio RM, Proud D, Kagey-Sobotka A, Freidhoff L, Norman PS, Lichtenstein LM. The effect of ceterizine on early allergic response. Laryngoscope 1989;99:5969.
  • 4
    Greiff L, Persson CGA, Svensson C, Enander I, Andersson M. Loratadine reduces allergen-induced mucosal output of α2-macroglobulin and tryptase in allergic rhinitis. J Allergy Clin Immunol 1995;96:97103.
  • 5
    Greiff L, Pipkom U, Alkner U, Persson CGA. The nasal pool-device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/seeretions. Clin Exp Allergy 1990;20:2539.
  • 6
    Thorell JI, Johansson BG. Enzymatic iodination of polypeptides to high activity. Biochim Biophys Acta 1971;251:3639.
  • 7
    Mygind N. Local effect of intranasal beclomethasone dipropionate in hay fever. BMJ 1973;4:4646.
  • 8
    Schata M, Jorde W, Richarz-Barthauer U. Levocabastine nasal spray better than sodium cromoglygate and placebo in the topical treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1991;87:8738.
  • 9
    Pelucchi A, Chiapparino A., Mastropasqua B, Marazzini L, Hernandez A, Foresi A. Effect of intranasal azelastine and beclomethasone dipropionate on nasal symptoms, nasal cytology, and bronchial responsiveness to methacholine in allergic rhinitis in response to grass pollens. J Allergy Clin Immunol 1995;95:51523.
  • 10
    Livostin Study Group. A comparison of topical levocabastine and oral terfenadine in the treatment of allergic rhinoconjunctivitis. Allergy 1993;48:5304.
  • 11
    Swedish GP Allergy Team. Topical levocabastine compared with oral loratadine for the treatment of seasonal allergic rhinoconjunctivitis. Allergy 1994;49;61115.
  • 12
    Simpson RJ. Budesonide and terfenadine. separately and in combination, in the treatment of hay fever. Ann Allergy 1994;73:497502.
  • 13
    Jordana G, Dolovich J, Briscoe Mp, et al. Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis. J Allergy Clin Immunol 1996;97:58895.
  • 14
    Tomiyama S, Ohnishi M, Okuda M. The use and duration of effect of levocabastine, a new topical H1 antagonist, on nasal provocation reaction to allergen. Am J Rhinol 1993;7;858.
  • 15
    De Graaf-in 't Veld T, Garrelds IM, Toorenbergen AW, Mulder PGH, van Wijk RG, Boegheim JPJ. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis. Ann Allergy Asthma Immunol 1995;75:2616.
  • 16
    Pazdrak K, Gorski P, Ruta U. Inhibitory effect of levocabastine on allergen-induced increase of nasal reactivity to histamine and cell influx. Allergy 1993;48:598601.
  • 17
    Wihl J-Å, Petersen BN, Petersen LN, Gundersen G, Bresson K, Mygind N. Effect of nonsedative H1-receptor antagonist astemizole in perennial allergic and nonallergic rhinitis. J Allergy Clin Immunol 1985;75:7207.
  • 18
    Persson CGA, Erjefält J, Andersson M, Greiff L, Svensson C. Extravasation, lamina propria flooding and luminal entry of bulk plasma in mucosal defence, inflammation and repair. Pulm Pharmacol 1996;9:12939.
  • 19
    Persson CGA, Erjefält I. Inflammatory leakage of macromolecules from the vascular compartment into the tracheal lumen. Acta Physiol Scand 1986;126:61516.
  • 20
    Svensson C, Klementsson H, Andersson M, Pipkorn U, Alkner U, Persson CGA. Glucocorticoid-induced attenuation of mucosal exudation of fibrinogen and bradykinins in seasonal allergic rhinitis. Allergy 1994;49:17783.
  • 21
    Klementsson H, Svensson C., Andersson M, Venge P, Pipkom U, Persson CGA. Eosinophils. secretory responsiveness, and glucocorticoid-induced effects of the nasal mucosa during a weak pollen season. Clin Exp Allergy 1991;21:70510.
  • 22
    Greiff L, Andersson M, Svensson C, Åkerlund A, Alkner U, Persson CGA. Effect of two weeks of topical budesonide treatment on microvascular exudative responsiveness in healthy human nasal airways. Eur Respir J 1997;10:8415.